Early repolarization syndrome (ERS) is an inherited cardiac arrhythmia syndrome associated with sudden cardiac death. Approaches to therapy are currently very limited. This study probes the mechanisms underlying the electrocardiographic and arrhythmic manifestation of experimental models of ERS and of the ameliorative effect of radiofrequency ablation.
arly repolarization (ER) pattern is characterized by J point elevation, distinct J waves with or without ST-segment elevation or slurring of the terminal part of the QRS in infero-lateral ECG leads. An ER pattern in the ECG has traditionally been regarded as benign.
1,2 A more malignant prognosis was suggested on the basis of experimental studies 3, 4 and subsequently confirmed in elegant clinical studies reported by Haïs-saguerre et al [5] [6] [7] and Nam et al. 6, 7 Further evidence in support of an association between ER pattern with arrhythmic risk was provided in a constant stream of clinical and experimental studies (reviews 4, [8] [9] [10] [11] ). The ionic and cellular mechanisms involved in generating ER patterns are similar to those responsible for J wave manifestation and ST-segment elevation in Brugada syndrome (BrS). 4 A net outward shift in the balance of current active during the early phases of the epicardial action potential (AP) secondary to reduction of I Ca or I Na or augmentation of I K-ATP have been shown to underlie the ER ECG pattern and the substrate responsible for the development of life-threatening arrhythmias associated with ER syndrome (ERS). 8, [12] [13] [14] [15] Although ERS and BrS differ with respect to the magnitude and lead location of abnormal J wave manifestation, they are thought to represent a continuous spectrum of phenotypic expression that we and others have termed J wave syndromes.
Approaches to therapy of ERS are currently very limited. 16 The pharmacological approach to therapy is similar to that prescribed for patients with the BrS, consisting of inhibition of the transient outward current (I to ) using agents such as quinidine and augmentation of calcium channel current using agents such as β-adrenergic agonists or phosphodiesterase III inhibitors. 12, [17] [18] [19] [20] [21] [22] Nademanee et al 23 provided another innovative approach to therapy of BrS using radiofrequency ablation (RFA) of the right ventricular outflow tract (RVOT). They recorded late potentials (LPs) and fractionated electrograms from the RVOT of BrS patients using bipolar electrograms and targeted these regions for RF ablation, which significantly reduced the arrhythmia-vulnerability and ECG-manifestation of the disease. Nademanee et al 23 concluded that the high-frequency LP and low-voltage fractionated electrogram activity were because of conduction delays within the RVOT and that elimination of these sites of slow conduction are the basis for the ameliorative effect of ablation therapy. We recently tested this hypothesis, 18 using coronary-perfused wedge models of BrS. We demonstrated that these manifestations were because of abnormal repolarization. The highfrequency LPs were because of concealed phase 2 reentry (P2R) and that the low-voltage fractionated electrogram activity recorded from RV epicardium was because of spatial dysynchrony in the appearance of the second upstroke of the right ventricular epicardial AP secondary to accentuation of the AP notch. 18 Moreover, our preliminary data strongly support the hypothesis that RFA is effective because it destroys the cells with the most prominent AP notch, thus eliminating the cells responsible for the repolarization abnormalities that give rise to P2R and ventricular tachycardia (VT)/ventricular fibrillation (VF). 24 Very limited data, principally in the form of case reports, are available about the effectiveness of RF ablation in ERS. 25, 26 There are however reports about suppression of triggering-premature ventricular contractions. Lim et al 27 reported highly fractionated electrogram activity in the epicardium of the RVOT and the anterior-inferior right ventricle. Ablation of the RVOT epicardium resulted in resolution of the Brugada pattern in the right precordial leads. However, the inferior ER persisted despite ablation of the inferior right ventricular epicardium. The patient remained event free during a 12-month follow-up period.
The present study was designed to probe the cellular basis for LPs associated with ERS and to explore the potential benefits and mechanisms underlying ablation therapy in ERS.
Using the left ventricular (LV) canine coronaryperfused wedge preparation, we assess the ability of bipolar epicardial electrograms to identify regions of abnormal repolarization and the ability of RF ablation to suppress the development of VT/VF.
WHAT IS KNOWN?
• Early repolarization syndrome and Brugada syndrome are inherited cardiac arrhythmia syndromes associated with sudden cardiac death.
• In patients with Brugada syndrome, radiofrequency ablation of low-voltage fractionated electrogram activity and high-frequency late potentials due to repolarization defects in the right ventricular outflow tract significantly reduces arrhythmia-vulnerability and the ECG-manifestation of Brugada syndrome.
WHAT THE STUDY ADDS?
• Low-voltage fractionated electrogram activity and high-frequency late potentials recorded from the left ventricular epicardium also identify regions of abnormal repolarization responsible for ventricular tachycardia or fibrillation in experimental models of early repolarization syndrome.
• Radiofrequency ablation of this left ventricular epicardial substrate suppresses ventricular tachycardia or fibrillation by destroying the epicardial cells displaying these regions of early repolarization.
METHODS

Wedge Preparations and Electrogram Recordings
All experiments were performed in compliance with the ) from the LV lateral or infero-lateral free wall. The preparations were cannulated via the second or third diagonal branch of the left anterior descending coronary artery and perfused with cardioplegic solution (Tyrode's containing 12 mmol/L KCl). Unperfused tissue was carefully removed using a razor blade. The preparations were then placed in a tissue bath and perfused with oxygenated Tyrode's solution (mmol/L): NaCl 129, KCl 4, NaH 2 PO 4 0.9, NaHCO 3 20, CaCl 2 1.8, MgSO 4 0.5, glucose 5.5, and pH 7.4. The perfusate was delivered using a roller pump (Cole Parmer Instrument Co, Niles, IL) at a constant flow rate at 8 to 10 mL/min warmed to 37±0.5°C.
The preparations were equilibrated in the tissue bath until electrically stable, usually 1 hour, while stimulated at a basic cycle length of 1000 ms using bipolar silver electrodes insulated except at the tips, applied to the endocardial surface. A transmural ECG was recorded using 2 electrodes consisting of AgCl half cells placed in the tissue bath, 1.0 to 1.5 cm from the epicardial and endocardial surfaces of the preparation, along the same axis as the transmembrane recordings (epicardial electrode is connected to the positive input of the ECG amplifier).
Transmembrane APs were simultaneously recorded from 2 epicardial (epicardial-1, epicardial-2 distance was ≈5-10 mm) and 1 endocardial site with the use of floating microelectrodes (DC resistance=10-20 MΩ) filled with 2.7 mol/L KCl, each connected to a high-input impedance amplifier. Impalements were obtained from the epicardial and endocardial surfaces of the preparation. Five unipolar electrodes were evenly distributed on the epicardial surface ( Figure 1A ). Seven virtual bipolar electrograms were derived by differential recording of the unipolar electrograms. Transmembrane action potentials (APs) were recorded using 2 glass microelectrodes positioned on the epicardial (epi) surface and 1 on the endocardial (endo) surface. Five unipolar electrodes were evenly distributed on the epicardial surface, permitting differential recording of 7 virtual bipolar electrograms. The ablation catheter was also used as a roving electrode to record bipolar electrograms. A pseudo ECG was recorded using AgCl electrodes placed across the bath positioned transmurally along the midline of the preparation (not shown). B, Method used to calculate J wave area; relative J wave area was normalized to R wave amplitude. C, Method used to calculate AP notch area; relative AP notch area was normalized to AP amplitude. AUC indicates area under the curve.
Measurements and Calculations
Spike2 for Windows (Cambridge Electronic Design, Cambridge, United Kingdom) was used to record and analyze the ECG, electrograms, and APs.
J wave area was calculated using Cursor Regions function of Spike2. The onset of the J wave (Jo) was set as defined by the recent consensus article by Macfarlane et al. 30 For a better basis of comparison, J wave area was normalized to R wave amplitude (J wave area r ; Figure 1B ).
AP notch area was calculated using Cursor Regions function of Spike2. The start of the notch was defined as the peak of phase 0. The end of the notch was determined as the peak of the phase 2 plateau. The upper limiting line of area measurement was defined as the horizontal cursor set to the peak of the phase 2 plateau. Here again, we normalized AP notch area to phase 2 amplitude (notch area r ; Figure 1C ).
Arrhythmia Induction and RFA
The I to agonist NS5806 (7-10 μmol/L), calcium channel blocker verapamil (3 μmol/L), and acetylcholine (1-3 μmol/L) were used to pharmacologically mimic ERS genotypes. Some arrhythmias developed spontaneously after exposure to the provocative agents during steady-state endocardial at a cycle length of 500 to 1000 ms. In some cases, arrhythmias were induced using single programmed electrical extrastimuli applied to the epicardial surface at coupling intervals approaching the effective refractory period.
RFA was performed in 6 preparations and 5 preparations served as time controls. RFA was applied using a radiofrequency generator (Stockert 70, Biosense Webster, CA) and an ablation catheter (7F, 4 mm tipped Livewire, St. Jude Medical, MN). Power settings were 35 W and 60°C. At each site, radiofrequency was delivered for 30 seconds. Soon after the final ablation, the provocative agents were washed out and the preparations were allowed to equilibrate in the tissue bath for a period of 3.5 to 5 hours. The provocative agents were then reintroduced in an attempt to once again induce arrhythmogenesis. Programmed electrical extrastimuli was repeated 30 to 40 minutes after reintroducing the provocative agents.
Statistical Analysis
For comparisons of parameters, Wilcoxon test and Friedman test were used, because the sample size is small and it had no normality. Data are shown as mean±SEM throughout the study.
RESULTS
Induction of Fractionated Electrogram Activity, LPs, P2R, and VT/VF
Under baseline conditions (control), a relatively small J wave was observed in 5 of 11 preparations (J wave area, 8.05±2.67 mV×ms) with essentially no J wave in the others. The I to agonist NS5806 (7-10 μmol/L), and calcium channel blocker verapamil (3 μmol/L) induced marked accentuation of the J wave (J wave area, 32.61±7.72 mV×ms), appearing as an ST-segment elevation in the ECG, secondary to accentuation of the AP notch in epicardium but not endocardium (Figure 2) . Figure 2A shows APs recorded from 1 endocardial site, 2 epicardial sites, and 2 subepicardial (M region) sites under baseline conditions. APs recorded from epicardium and M region, but not endocardium, display a modest AP notch coincident with the J wave in the ECG. Addition of NS5806 (10 μmol/L), verapamil (3 μmol/L), and acetylcholine (ACh; 2 μmol/L) to the coronary perfusate caused a marked accentuation of the AP notch in epicardium but not endocardium giving rise to a pronounced J wave manifest as an ST-segment elevation as well as a concealed P2R (Figure 2B) . The concealed P2R gives rise to a discrete high-frequency LP in the bipolar electrogram. The bipolar electrograms also show low-voltage fractionated electrogram activity because of the loss of synchrony in the appearance of the epicardial AP dome. Acceleration of endocardial stimulation rate from a basic cycle length of 1000 to 600 ms led to disappearance of the fractionated electrogram activity and LPs because of synchronization in the appearance of the epicardial AP dome and elimination of the concealed P2R, respectively. (Figure 2C ). The type I ST-segment elevation persisted, although with a diminished J wave because of the reduction in the magnitude of the epicardial AP notch.
In another series of experiments, we ablated the epicardial regions displaying the abnormal repolarization activity responsible for the fractionated electrogram activity and LPs. Figures 3 and 4 illustrate typical examples. Figure 3A shows bipolar electrogram activity, transmembrane AP, and ECG recorded under baseline conditions with basic stimulation applied to endocardium. Figure 3B shows a marked accentuation of the J wave (ST-segment elevation) because of the accentuation of the AP notch in epicardium by not endocardium after addition of the provocative agents (9 μmol/L NS5806, 3 μmol/L verapamil, and 1 μmol/L ACh). In Figure 3B and 3C, the AP dome was lost at the Epi-2 recording site but maintained at the Epi-1 recording site, leading to development of P2R, which gave rise to a closely coupled single and double extrasystoles ( Figure 3B and 3C, respectively) . In Figure 3D ), the extrasystole precipitated polymorphic VT. The bipolar electrogram recordings displayed low-voltage fractionated electrical activity in epicardium (<1 mV) because 
ERS).
The I to agonist NS5806 (9 μmol/L), calcium channel blocker verapamil (3 μmol/L), and acetylcholine (1 μmol/L) induced prominent J waves in the ECG secondary to accentuation of the action potential (AP) notch in epicardium (epi) but not endocardium (endo; B). The bipolar electrogram (EG) recordings displayed low-voltage fractionated EG activity (<1 mV) in epicardium because of temporal and spatial variability in appearance of the AP dome (B and C). Propagation of the dome from Epi-1 to Epi-2 sites induced phase 2 reentry (C), which precipitated polymorphic ventricular tachycardia (D). Immediately after RFA, prominent ST elevation developed because of injury currents, which largely dissipated over a period of 1 h. F was recorded after reintroduction of the provocative agents 5 h after RFA. AP notch recorded from the deep subepicardium (M region) was markedly reduced as was the J wave in the ECG. All arrhythmic activity was abolished and could not be induced with programmed electrical extrastimuli.
of temporal and spatial variability in the appearance of the epicardial AP dome. The low-voltage fractionated potentials averaged 0.58±0.14 mV, with duration of 196 ms from the end of the R wave of the ECG. P2R subsequently gave rise to polymorphic VT ( Figure 3D ).
RF ablation of the sites of abnormal repolarization, characterized by fractionated bipolar electrogram activity and LPs, initially resulted in a further accentuation of ST-segment elevation because of injury currents (Figure 3E) . The injury currents largely subsided over a period of ≈1 hour. Figure 3F shows activity recorded 5 hours after RFA. Transmembrane AP activity could no longer be recorded from the ablated epicardium. The APs shown were recorded from the deep subepicardium (M region). RFA greatly diminished the AP notch and J wave area and abolished all arrhythmic activity. RFA was applied to nearly the entire epicardial surface. Power settings were 35 W and 60°C. Radiofrequency was delivered for 30 seconds at each point. With this power and delivery time, ≈20% of LV wall thickness was necrotized.
In many preparations, we observed the development of concealed P2R when the AP dome was lost at some epicardial sites but not others. The development of a P2R-mediated closely coupled extrasystole in epicardium without propagation to the rest of the preparation gave rise to a discrete high-frequency LP in the epicardial electrogram (eg, Figures 2B and 4B) . The high-frequency LPs appeared with a delay of 148 and 169 ms in these 2 cases. In Figure 4C and 4D, P2R is observed to successfully propagated to endocardium to produce a closely coupled extrasystole ( Figure 4C ) and polymorphic VT ( Figure 4D ). It is noteworthy the AP within which the dome was maintained is out of the field of view of the recording electrodes. Here again RFA dramatically reduced J wave amplitude and abolished all arrhythmic activity ( Figure 4F ). Successful propagation of the P2R beat precipitated VT/VF in 10 of 11 preparations (90.9%). RFA of the epicardium suppressed the J waves by destroying the cells displaying abnormal repolarization, thus suppressing the development of VT/VF in 6 of 6 preparations (100%). It is difficult to evaluate the ameliorative effect on the amplitude of J waves immediately after RFA because of the injury currents that develop. This effect of RFA dissipated over a period of 1 hour. Reintroduction of the provocative agents 3.5 to 5 hours after epicardial RFA yielded much reduced J waves in all preparations (100%; Figures 3 and 4) .
Time Controls
Finally, in 5 preparations, we performed a time control to assess the effects of the provocative agents over a period of 5 hours. Accentuation of the epicardial AP notch and electrocardiographic J wave increased progressively over a period of 20 to 30 minutes. At times, VT developed spontaneously. After 30 minutes of exposure to the provocative agents, recordings were obtained and the provocative agents were washed out. In all cases, reintroduction of the provocative agents 3.5 to 5 hours later yielded similar responsiveness of the preparations after 20 to 30 minutes of drug exposure (Figures 5 and 6) . Table I in the Data Supplement summarizes electrogram findings for each preparation. Most episodes of VT/VFs developed spontaneously. In 1 of 6 ablation preparations and 1 of 5-time controls, episodes of VT/ VF were induced using a single programmed electrical extrastimuli applied to the epicardial surface. In 5 of 6 preparations, nearly complete suppression of the J wave was observed. The other case showed >50% decrease in the area of the J wave after ablation. Figure 6 ).
Low-voltage fractionated potentials were observed in 3 of 6 preparations before RFA. The high-frequency spikes were observed in 6 of 6 preparations before RFA. After epicardial RFA, fractionated electrogram activity and LPs were not observed in any preparation and VT/ VF was totally suppressed and could not be induced (Table I in 
DISCUSSION
ERS is an inherited cardiac arrhythmia syndrome associated with sudden cardiac death. It has been divided into 3 subtypes. 4 In type 1, the ER pattern is present in the lateral leads. Type 2 involves an ER pattern localized to the inferior and infero-lateral leads, and in type 3 it is present globally in the inferior, lateral, and anterior or right precordial leads. Individuals displaying type 1 rarely develop VT/VF. Type 2 is associated with a higher level of risk and individuals with a type 3 have the highest risk for developing life-threatening arrhythmias. 4 ERS has been associated with gain of function mutations in the pore-forming subunit of the ATP-sensitive potassium channel (KCNJ8), 14, 15 loss of function mutations in the α1, β2, and α2δ subunits of the cardiac L-type calcium channel (CACNA1C, CACNB2, and CAC-NA2D1), 13 and the loss of function mutations in sodium channel activity (SCN5A). Moreover, the greater vulnerability of the inferior wall of LV to ER influences has been ascribed to the presence of a higher density of the transient outward current (I to ).
12 Both electrocardiographic and arrhythmic features of ER and ERS are known to be enhanced by vagal influences. [31] [32] [33] [34] [35] [36] We pharmacologically modeled the conditions (prominent I to ) and genetic defects (I Ca block) associated with ERS using NS5806 to increase I to , ACh to mimic increased vagal activity, and the I Ca blocker verapamil to mimic loss of function mutation in calcium channel activity, calcium inward current (I Ca ). The outward shift in the balance of current flowing during the early phase of the LV epicardial AP led to accentuation of the J wave, thus giving rise to an ERS substrate capable of inducing P2R and polymorphic VT/VF. These observations are consistent with those reported by Koncz et al, 12 who presented evidence that ERS is caused by a preferential accentuation of the AP notch in LV epicardium, that this repolarization defect is accentuated by ACh, and that higher intrinsic levels of I to account for the greater sensitivity of the inferior LV wall to development of VT/VF.
Our ERS models displayed low-voltage fractionated electrogram activity and LPs similar to the activity reported by Nademanee et al 23 in the RVOT of patients with BrS and by Nakagawa in the LV of patients with ERS. Nakagawa et al 37 recorded unipolar and bipolar epicardial electrograms directly from the LV of patients diagnosed with ERS by introducing a multipolar catheter into the left lateral (marginal) coronary vein, anterior interventricular vein, and middle cardiac vein via the coronary sinus.
Our results provide evidence in support of the hypothesis that in the setting of ERS, LPs, and fractionated electrogram activity are due to abnormal repolarization rather than abnormal depolarization or conduction, as recently also shown for similar activity observed in experimental models of BrS. 18 The present study assessed the ability of bipolar epicardial electrograms to identify regions of abnormal repolarization. The low-voltage fractionated potentials were visible at the end of QRS and sustained for certain duration. Concealed P2R developed when AP dome was lost at some epicardial sites but not others, appearing in the bipolar electrogram as discrete high-frequency spikes, which were associated with isolated intraepicardial concealed beats without propagation. In the present study, low-voltage fractionated potentials were observed in 5 of 9 preparations and high-frequency LPs were observed in 9 of 9 preparations (Table I in the Data Supplement). RFA of these sites of abnormal repolarization was successful in reducing the electrocardiographic and abolishing the arrhythmic manifestation of ERS by destroying the cells with the most prominent AP notch responsible for the development of the prominent J waves, P2R, and VT/VF.
These findings suggest that areas of low-voltage fractionated potentials and high-frequency spikes within LV epicardium could identify regions to be targeted for RFA. The radiofrequency energy applied ablated up to 20% of the LV wall. The degree to which this could impact contractility or ejection fraction is not known and will need to be determined.
Whereas in BrS, the region targeted for ablation is generally the RVOT, experimental, 12 and clinical 35, [38] [39] [40] [41] [42] [43] [44] [45] studies point to the inferior region of LV as the principal culprit in the setting of ERS. 12, 35, [38] [39] [40] [41] [42] [43] [44] [45] The greater vulnerability of the inferior wall of the LV has been ascribed to a higher density of I to in this region of ventricular epi- Figure 6 . Effect of early repolarization syndrome provoking agents on J wave area and action potential (AP) notch area before and after epicardial ablation. A, J wave area recorded in the absence and presence of provocative agents before and after epicardial ablation or time control of exposure to the provocative agents over a period of up to 5 h. B, J wave area normalized to R wave amplitude recorded in the absence and presence of provocative agents before and after epicardial ablation or time control. C, AP area recorded in the absence and presence of provocative agents before and after epicardial ablation or time control of exposure to the provocative agents for a period of up to 5 h. D, AP notch area normalized to phase 2 amplitude recorded in the absence and presence of provocative agents before and after epicardial ablation or time control. The addition of the provocative agents, significantly increased J wave area and AP notch area, which was greatly reduced after epicardial ablation.
cardium. 12 In type 3 ER, the arrhythmogenic substrates could be distributed widely on epicardial surface both in RV and LV and may not be amenable to RF ablation.
CONCLUSIONS
Our findings suggest that low-voltage fractionated electrogram activity and high-frequency potentials recorded from the epicardial surface of the LV can identify the substrate responsible for VT/VF in ERS and that RFA of these regions of LV epicardium can suppress the vulnerability to development of VT/VF by destroying regions of ER. The present study is the first to show that RFA of LV epicardium may lead to prevention of recurrent VT/ VF in the setting of ERS. 16 
Study Limitations
As with all studies involving experimental animal models, extrapolation of the data to the clinic should be done with great care.
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